Physician profile
Sandra V Puerto
NPI 1972941961
$1,558.34
in general payments reported to CMS, 2019-2025
8 companies · $250 in 2025
The $250 reported for 2025 was more than what 80% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $300 · 2022: $35.66 · 2023: $145 · 2024: $828 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,055 · Consulting Fee: $158 · Education: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,054.63 |
| Consulting Fee | $158.49 |
| Education | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,185.88 | 2021-2025 | Invisalign, Itero Element 5d Plus Lite |
| Sprintray INC | $95.63 | 2024 | Pro 2 3d Printer |
| Biohorizons Implant Systems INC. | $94.62 | 2021-2024 | Biohorizons |
| Zimmer Biomet Holdings, INC. | $57.69 | 2021 | |
| Orapharma, A Division of Bausch Health US, LLC | $56.81 | 2022-2025 | Arestin |
| Gc America INC. | $48.22 | 2025 | Cytrans Granules |
| Voco America INC. | $11.00 | 2021 | |
| Sonendo INC | $8.49 | 2023 | Gentlewave Console |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Puerto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.